Back to top
more

Inogen (INGN)

(Delayed Data from NSDQ)

$9.25 USD

9.25
185,143

+0.22 (2.44%)

Updated Jul 19, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

UnitedHealth's Senior Unsecured Notes Rated by A.M Best

by Zacks Equity Research

UnitedHealth Group, Inc.'s (UNH) senior unsecured notes recently received rating action from A.M Best.

    Earnings Estimates Moving Higher for Inogen (INGN): Time to Buy?

    by Zacks Equity Research

    Inogen (INGN) has seen positive earnings estimate revisions for the current quarter and year, in addition to decent short-term price momentum.

      VWR Corporation (VWR): Q4 Lacks Shine, Currency Woes Remain

      by Zacks Equity Research

      On Mar 9, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR) -- a global provider of products, services and solutions to laboratory and production facilities.

        Swarup Gupta headshot

        4 Big Winners of Trump's Healthcare Plan

        by Swarup Gupta

        The new healthcare legislation has its own sets of winners and losers.

          3 Reasons Why Inogen (INGN) is a Great Momentum Stock

          by Zacks Equity Research

          Let's focus on Inogen, Inc. (INGN) as this momentum stock is looking especially impressive right now.

            Walgreens Boots Grapples with Headwinds: Should You Dump?

            by Zacks Equity Research

            On Mar 8, we issued an updated research report on Illinois-based leading pharmacy-led, health and wellbeing enterprise Walgreens Boots Alliance, Inc. (WBA).

              Community Health Prices Senior Secured Notes Worth $2.2B

              by Zacks Equity Research

              Community Health Systems, Inc. (CYH) recently announced that it has issued 6.25%, $2.2 billion Senior Secured Notes, due 2023. The offering was upsized by $450 million.

                CVS Health Adopts Epic EHR for Specialty Care Programs

                by Zacks Equity Research

                CVS Health Corporation (CVS) recently announced that it has chosen Epic as the electronic health record (EHR) system for CVS Specialty's care management programs.

                  BioScrip (BIOS): Q4 Loss Narrower than Expected, Sales Top

                  by Zacks Equity Research

                  BioScrip, Inc. (BIOS) reported net loss from continuing operations of $5.2 million or loss of 6 cents per share in the fourth quarter of 2016, much narrower than the year-ago net loss of $16.9 million or loss of 28 cents.

                    Inogen (INGN) Tops Earnings & Revenues in Q4; View Upbeat

                    by Zacks Equity Research

                    Inogen Inc. (INGN) reported fourth-quarter 2016 earnings of 25 cents per share, which surpassed both the Zacks Consensus Estimate by 15 cents and the year-ago figure by 11 cents.

                      athenahealth (ATHN) Beats on Q4 Earnings, Misses Revenues

                      by Zacks Equity Research

                      athenahealth (ATHN) reported adjusted earnings of 42 cents per share, which beat the Zacks Consensus Estimate of 27 cents.

                        PerkinElmer (PKI) Misses Q4 Earnings & Revenue Estimates

                        by Zacks Equity Research

                        Waltham, MA-based PerkinElmer Inc (PKI) reported fourth-quarter 2016 earnings of 83 cents per share missing the Zacks Consensus Estimate of 86 cents

                          CONMED (CNMD) Q4 Earnings Miss Estimates, Increase Y/Y

                          by Zacks Equity Research

                          Headquartered in Utica, NY, leading medical technology player, CONMED Corporation (CNMD) reported fourth-quarter 2016 adjusted earnings of 54 cents per share, missing the Zacks Consensus Estimate by 2 cents.

                            Baxter International (BAX) Q4 Earnings Beat, Revenues Lag

                            by Zacks Equity Research

                            Baxter International Inc. (BAX) reported fourth-quarter 2016 adjusted earnings of 57 cents per share, which surpassed the Zacks Consensus Estimate by 5 cents and were well above the year-ago figure of 43 cents.

                              Glaukos (GKOS) Catches Eye: Stock Adds 5.6% in Session

                              by Zacks Equity Research

                              Glaukos Corporation (GKOS) moved big last session, as its shares jumped almost 6% on the day.

                                Inogen (INGN) Affirms Outlook and Shuffles Top Management

                                by Zacks Equity Research

                                Inogen, Inc. (INGN) reiterated its fiscal 2016 outlook and appointed a new President cum Chief Executive Officer.

                                  Kevin Matras headshot

                                  Top Stocks with Big Potential Catch-Up Moves

                                  by Kevin Matras

                                  Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include CSGP, CW, HLS, INGN and PKI.